Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Laudani

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Heart (British Cardiac Society)|September 14, 2025
On the role of guideline-directed medical therapy in current generation PCIClaudio Laudani
JACC. Cardiovascular Interventions|April 3, 2022
Culprit Lesions Phenotypes in ST-Segment Elevation Acute Coronary Syndromes: A Call for Precision MedicineDavide Capodanno, Claudio Laudani
European Heart Journal|July 9, 2026
Rethinking antiplatelet evidence through the lens of ethnicityClaudio Laudani, Mattia Galli
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Platelet reactivity when switching from cangrelor to oral P2Y12 receptor inhibitors: insights from a real-world registryFrancesco Franchi, Claudio Laudani
Circulation. Cardiovascular Interventions|August 23, 2023
Unraveling the Maze of De-Escalation Strategies in Acute Coronary SyndromesDavide Capodanno, Claudio Laudani
JACC. Cardiovascular Interventions|June 6, 2024
Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI: Translating Pharmacodynamic Into Clinical EvidenceClaudio Laudani, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy|June 2, 2025
Entering a new era of antiplatelet therapy: the 4D-ACS trialClaudio Laudani, Felice Gragnano, Mattia Galli
Expert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Drug Safety|December 4, 2023
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and managementClaudio Laudani, Davide Capodanno, Dominick Joseph Angiolillo
Interventional Cardiology (London, England)|August 21, 2023
Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European PerspectiveAntonio Greco, Claudio Laudani, Carla Rochira, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Heart (British Cardiac Society)|September 14, 2025
On the role of guideline-directed medical therapy in current generation PCIClaudio Laudani
JACC. Cardiovascular Interventions|April 3, 2022
Culprit Lesions Phenotypes in ST-Segment Elevation Acute Coronary Syndromes: A Call for Precision MedicineDavide Capodanno, Claudio Laudani
European Heart Journal|July 9, 2026
Rethinking antiplatelet evidence through the lens of ethnicityClaudio Laudani, Mattia Galli
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2025
Platelet reactivity when switching from cangrelor to oral P2Y12 receptor inhibitors: insights from a real-world registryFrancesco Franchi, Claudio Laudani
Circulation. Cardiovascular Interventions|August 23, 2023
Unraveling the Maze of De-Escalation Strategies in Acute Coronary SyndromesDavide Capodanno, Claudio Laudani
JACC. Cardiovascular Interventions|June 6, 2024
Ticagrelor in Clopidogrel-Treated Patients With Chronic Coronary Syndrome Undergoing PCI: Translating Pharmacodynamic Into Clinical EvidenceClaudio Laudani, Dominick J Angiolillo
European Heart Journal. Cardiovascular Pharmacotherapy|June 2, 2025
Entering a new era of antiplatelet therapy: the 4D-ACS trialClaudio Laudani, Felice Gragnano, Mattia Galli
Expert Opinion on Pharmacotherapy|July 24, 2024
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic strokeClaudio Laudani, Davide Capodanno, Dominick J Angiolillo
Expert Opinion on Drug Safety|December 4, 2023
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and managementClaudio Laudani, Davide Capodanno, Dominick Joseph Angiolillo
Interventional Cardiology (London, England)|August 21, 2023
Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European PerspectiveAntonio Greco, Claudio Laudani, Carla Rochira, et al.
Pageof 8